Indeed, Pip/Tazo achieves ELF and ISF/plasma ratios ≥0.5X [21], meaning that standard dose regimens (i.e., 4/0.5 g q6h) may be considered effective for treatment of infections, but not for preventing the selection of mutant clones in some cases [38]. This evidence concerns the gene PIP and infection.